Studienliteratur zu den Nephroblastomen (Wilms-Tumoren)

Zuletzt geändert: 20.05.2026 https://kinderkrebsinfo.de/doi/e123837

Studienliteratur Nephroblastome

Pubmed

  1. Meier CM, Furtwängler R, Welter N, Mergen M, Wagenpfeil S, von Schweinitz D, Stein R, Kager L, Schenk JP, Vokuhl C, Kroiss-Benninger S, Melchior P, Warmann SW, Fuchs J, Graf N: Can Lymph Node Involvement in Unilateral Wilms Tumor be Predicted by Preoperatively known Data in Combination with Intraoperative Findings? Annals of surgery 2026, 283: 162 [PMID: 38864214] MEI2026
  2. Mergen M, Graf N, Welter N, Melchior P, Vokuhl C, Schmidt A, Kroiss-Benninger S, Kager L, Schenk JP, Furtwängler R: Efficacy of Preoperative Chemotherapy in Patients With Nephroblastoma and Imaging Findings Suggestive of Preoperative Tumor Rupture. Pediatric blood & cancer 2026, 73:e32111 [PMID: 41069077] MER2026
  3. Tagarelli A, Dandis R, Van Tinteren H, Furtwängler R, Al-Saadi R, Chowdhury T, Ramirez-Villar GL, de Camargo B, Schenk JP, Teixeira RAP, van Grotel M, Brok J, Brisse HJ, Serra A, Graf N, Verschuur A, van den Heuvel-Eibrink MM: Characteristics and Survival of Patients With Wilms Tumor and Bone Metastases: A SIOP-RTSG 93-01, SIOP 2001, and UK-IMPORT Study. Pediatric blood & cancer 2026,e70270 [PMID: 42003563] TAG2026
  4. Welter N, Schenk JP, Wegert J, Gessler M, Kager L, Wagenpfeil S, Müller M, Wolff JM, Fuchs J, Warmann SW, Meier CM, Hubertus J, Rübe C, Vokuhl C, Melchior P, Tschirner L, Graf N, Furtwängler R: The Fate (Outcome) of Clinically Apparent Single Lesion and Oligofocal Nephroblastomatosis Treated According to SIOP/GPOH Protocols for Wilms Tumor. Pediatric blood & cancer 2026,:e70354 [PMID: 42053023] WEL2026
  5. Oller A, Kemmeren P, Perotti D, van Tinteren H, Verschuur A, Spreafico F, Brok J, Furtwängler RCJ, Chowdhury T, Al-Saadi R, Vujanic GM, Treece AL, Drost J, van Grotel M, Mullen EA, Evageliou NF, Graf N, Hong AL, Gessler M, Geller JI, van den Heuvel-Eibrink MM: Systematic Review: Prognostic Molecular Biomarkers in Wilms Tumors. JCO precision oncology 2026, 10:e2501017 [PMID: 42150146] OLL2026
  6. Furtwängler R, Dandis R, van Tinteren H, Welter N, Vokuhl C, Vujanic G, Coulomb-L'Hermine A, Godzinski J, Schenk JP, Brisse H, Gessler M, Kager L, Melchior P, Warmann SW, Verschuur A, de Camargo B, Ramirez-Villar G, Spreafico F, Brok J, Chowdhury T, van den Heuvel-Eibrink MM, Graf N: Residual Absolute Volume of Blastema as a Predictor of Clinical Outcomes in Patients With Wilms Tumor: A Report From the SIOP WT 2001 Study. Journal of clinical oncology 2026,JCO2501755 [PMID: 41824924] FUR2026
  7. Treger TD, Wegert J, Wenger A, Coorens THH, Al-Saadi R, Kemps PG, Kennedy J, Parks C, Anderson ND, Hodder A, Letunovska A, Jung H, Ogbonnah T, Trinh MK, Lee-Six H, Morcrette G, van den Heuvel-Eibrink MM, Drost J, van Boxtel R, Bertrums EJM, Goemans BF, Antoniou E, Reinhardt D, Streitenberger H, Ziegler B, Bartram J, Hutchinson JC, Vujanic GM, Vokuhl C, Chowdhury T, Furtwängler R, Graf N, Pritchard-Jones K, Gessler M, Behjati S: Predisposition Footprints in the Somatic Genome of Wilms Tumors. Cancer discovery 2025, 15: 286 [PMID: 39665570] TRE2025
  8. Götz L, Wegert J, Paikari A, Appenzeller S, Bausenwein S, Vokuhl C, Treger TD, Drost J, Linderkamp C, Schneider DT, Ernestus K, Warman SW, Fuchs J, Welter N, Graf N, Behjati S, Furtwängler R, Gessler M: Wilms tumor primary cultures capture phenotypic heterogeneity and facilitate preclinical screening. Translational oncology 2025, 52: 102263 [PMID: 39740515] GOE2025
  9. Perotti D, O'Sullivan MJ, Walz AL, Davick J, Al-Saadi R, Benedetti DJ, Brzezinski J, Ciceri S, Cost NG, Dome JS, Drost J, Evageliou N, Furtwängler R, Graf N, Maschietto M, Mullen EA, Murphy AJ, Ortiz MV, van der Beek JN, Verschuur A, Wegert J, Williams R, Spreafico F, Geller JI, van den Heuvel-Eibrink MM, Hong AL: Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers. Nature reviews. Urology 2025, 22: 526 [PMID: 39881003] PER2025
  10. Welter N, Al-Saadi R, Gravier-Dumonceau R, Furtwängler R, Graf N, Wegert J, Gessler M, Williams RD, Pritchard-Jones K, Coulomb-L'Hermine A, van den Heuvel-Eibrink MM, Verschuur AC: The Clinical Impact of Somatic Copy Number Variations in Patients With Stage IV Wilms Tumor Enrolled in the SIOP 2001 Trial and Study. Pediatric blood & cancer 2025, 72:e31580 [PMID: 39895484] WEL2025
  11. Meyerheim M, Panagiotidou F, Georgiadi E, Soudris D, Stamatakos G, Graf N: Exploring the in silico adaptation of the Nephroblastoma Oncosimulator to MRI scans, treatment data, and histological profiles of patients from different risk groups. Frontiers in physiology 2025, 16: 1465631 [PMID: 40313874] MEY2025
  12. Wegert J, Appenzeller S, Treger TD, Streitenberger H, Ziegler B, Bausenwein S, Vokuhl C, Parks C, Jüttner E, Gramlich S, Ernestus K, Warman SW, Fuchs J, Hubertus J, von Schweinitz D, Fröhlich B, Jorch N, Knöfler R, Friedrich C, Corbacioglu S, Frühwald MC, Pekrun A, Schneider DT, Faber J, Stursberg J, Metzler M, Welter N, Pritchard-Jones K, Graf N, Furtwängler R, Behjati S, Gessler M: Distinct pathways for genetic and epigenetic predisposition in familial and bilateral Wilms tumor. Genome medicine 2025, 17: 49 [PMID: 40340749] WEG2025
  13. Sutton KS, Walz AL, Groenendijk A, Murphy AJ, Pater L, Janssens GO, Brzezinski J, Mullen EA, Spreafico F, Godzinski J, van der Beek J, Hwa Wijnen M, van den Heuvel-Eibrink MM, Pachl M, Graf N, Ehrlich PF, Furtwangler R, Brok J, Geller J: Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives. Pediatric blood & cancer 2025, 72:e31790 [PMID: 40369656] SUT2025
  14. Wens FSPL, Zonca F, van Tinteren H, Timmermann B, Laprie A, Boterberg T, Gaze M, Lim P, Jazmati D, Dieckmann K, Vennarini S, Melchior P, Weber B, Albiac MR, Szulc A, Grigorenko V, Magelssen H, van Beek K, Graf N, Papadakis V, Neggers SJCMM, van den Heuvel-Eibrink MM, Janssens GO, Polak R: Late toxicity after upper abdominal radiotherapy in pediatric Wilms tumor and neuroblastoma survivors. A systematic review on behalf of SIOPEN and SIOP-RTSG. Radiotherapy and oncology 2025, 209: 110961 [PMID: 40441488] WEN2025
  15. Groenendijk A, van Tinteren H, de Krijger RR, Vujanic G, Al-Saadi R, Pritchard-Jones K, Ramírez-Villar GL, Melchior P, Godzinski J, Schenk JP, Graf N, Segers H, Sudour-Bonnange H, Verschuur AC, Drost J, Perotti D, Al-Jilaihawi S, Brok J, van den Heuvel-Eibrink MM, Spreafico F, Mavinkurve-Groothuis AMC: Outcome of patients with a first relapse after intermediate- or high-risk Wilms tumor, treated according to SIOP WT 2001/UK-IMPORT study; A report from the SIOP renal tumor study group. Urologic oncology 2025, 43: 525.e19-525.e32 [PMID: 40545412] GRO2025
  16. Suttorp M, Sembill S, Lensker P, Hildebrand V, Schirmer E, Karow A, Krumbholz M, Rauh M, Metzler M: Therapeutic drug monitoring of imatinib in paediatric chronic myeloid leukaemia: Data from a real-world setting. British journal of haematology 2025, 206: 1397 [PMID: 40059620] SUT2025
  17. Vujanić GM, Graf N, D'Hooghe E, Pritchard-Jones K, Bergeron C, Tinteren HV, Furtwängler R, International Society of Paediatric Oncology Renal Tumour Study Group (SIOP-RTSG): Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30-year SIOP-RTSG experience. Pediatric blood & cancer 2024, 71:e30852 [PMID: 38185745] VUJ2024
  18. Welter N, Metternich G, Furtwängler R, Bayoumi A, Mergen M, Kager L, Vokuhl C, Warmann SW, Fuchs J, Meier CM, Melchior P, Gessler M, Wagenpfeil S, Schenk JP, Graf N: How to improve initial diagnostic accuracy of kidney tumours in childhood?-A non-invasive approach. International journal of cancer 2024, 154: 1955 [PMID: 38319190] WEL2024
  19. van der Beek JN, Schenk JP, Morosi C, Watson TA, Coma A, Graf N, Chowdhury T, Ramírez-Villar GL, Spreafico F, Welter N, Dzhuma K, van Tinteren H, de Krijger RR, van den Heuvel-Eibrink MM, Littooij AS: Diagnostic magnetic resonance imaging characteristics of congenital mesoblastic nephroma: a retrospective multi-center International Society of Pediatric Oncology-Renal Tumor Study Group (SIOP-RTSG) radiology panel study. Pediatric radiology 2024, 54: 965 [PMID: 38609702] BEE2024
  20. Mergen M, Welter N, Furtwängler R, Melchior P, Vokuhl C, Gessler M, Meier CM, Kager L, Schenk JP, Graf N: The impact of the route to diagnosis in nephroblastoma. Cancer medicine 2024, 13:e7226 [PMID: 38785181] MER2024
  21. Sudour-Bonnange H, van Tinteren H, Ramírez-Villar GL, Godzinski J, Irtan S, Gessler M, Chowdhury T, Audry G, Fuchs J, Powis M, van de Ven CP, Okoye B, Smeulders N, Vujanic GM, Verschuur A, L'Herminé-Coulomb A, de Camargo B, de Aguirre Neto JC, Schenk JP, van den Heuvel-Eibrink MM, Pritchard-Jones K, Graf N, Bergeron C, Furtwängler R: Characteristics and outcome of synchronous bilateral Wilms tumour in the SIOP WT 2001 Study: Report from the SIOP Renal Tumour Study Group (SIOP-RTSG). British journal of cancer 2024, 131: 972 [PMID: 39080350] SUD2024
  22. Sprokkerieft J, van der Beek JN, Spreafico F, Selle B, Chowdhury T, Graf N, Verschuur AC, Dandis R, Bex A, Geller JI, Tytgat GAM, van den Heuvel-Eibrink MM: Outcome after treatment with axitinib in children, young adults, and adults with renal cell carcinoma: a narrative review. Critical reviews in oncology/hematology 2024, 204: 104523 [PMID: 39326645] SPR2024
  23. Sprüssel A, Suzuki T, Miyata N, Astrahantseff K, Szymansky A, Toedling J, Thole-Kliesch TM, Ballagee A, Lodrini M, Künkele A, Truss M, Heukamp LC, Mathia S, Hertwig F, Rosenberger C, Eggert A, Deubzer HE, Schulte JH: Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis. Journal of clinical medicine 2024, 13 [PMID: 39458030] SPR2024
  24. Welte K: Forty years of human G-CSF: A short history in time. British journal of haematology 2024, 205: 1296 [PMID: 39158170] WEL2024
  25. Meier CM, Fuchs J, von Schweinitz D, Stein R, Wagenpfeil S, Kager L, Schenk JP, Vokuhl C, Melchior P, Welter N, Furtwängler R, Graf N: Surgical Factors Influencing Local Relapse and Outcome in the Treatment of Unilateral Nephroblastoma. Annals of surgery 2023, 278:e360-e367 [PMID: 36017935] MEI2023a
  26. Politis G, Wagenpfeil S, Welter N, Mergen M, Furtwängler R, Graf N: An Observational Case-Control Study on Parental Age and Childhood Renal Tumors. Cancers 2023, 15 [PMID: 37958318] POL2023
  27. van den Heuvel-Eibrink MM, Fernandez CV, Graf N, Geller JI: Progress by international collaboration for pediatric renal tumors by HARMONIzation and COllaboration: The HARMONICA initiative. Pediatric blood & cancer 2023, 70 Suppl 2:e30082 [PMID: 36426385] HEU2023
  28. Vujanić GM, Graf N, D'Hooghe E, Chowdhury T, Vokuhl C, Al-Saadi R, Pritchard-Jones K, Melchior P, Furtwängler R: Outcomes of patients with Wilms' tumour stage III due to positive resection margins only: An analysis of patients treated on the SIOP-WT-2001 protocol in the UK-CCLG and GPOH studies. International journal of cancer 2023, 152: 1640 [PMID: 36444500] VUJ2023
  29. Meier CM, Furtwängler R, Mergen M, Welter N, Melchior P, Schenk JP, Vokuhl C, Kager L, Kroiss-Benninger S, Wagenpfeil S, Graf N: Impact of Time to Surgery on Outcome in Wilms Tumor Treated with Preoperative Chemotherapy. Cancers 2023, 15 [PMID: 36900286] MEI2023
  30. Perotti D, Williams RD, Wegert J, Brzezinski J, Maschietto M, Ciceri S, Gisselsson D, Gadd S, Walz AL, Furtwaengler R, Drost J, Al-Saadi R, Evageliou N, Gooskens SL, Hong AL, Murphy AJ, Ortiz MV, O'Sullivan MJ, Mullen EA, van den Heuvel-Eibrink MM, Fernandez CV, Graf N, Grundy PE, Geller JI, Dome JS, Perlman EJ, Gessler M, Huff V, Pritchard-Jones K: Hallmark discoveries in the biology of Wilms tumour. Nature reviews. Urology 2023 Oct 17; [PMID: 37848532] PER2023
  31. Politis G, Wagenpfeil S, Welter N, Mergen M, Furtwängler R, Graf N: An Observational Case-Control Study on Parental Age and Childhood Renal Tumors. Cancers 2023, 15 [PMID: 37958318] POL2023
  32. Pettit C, Kanagaratnam R, Coughlan F, Graf N, Hahn D, Durkan A: Kidney biopsy adequacy and complications in children - does technique matter? European journal of pediatrics 2022, 181: 2677 [PMID: 35414029] PET2022c
  33. Weißert K, Ammann S, Kögl T, Dettmer-Monaco V, Schell C, Cathomen T, Ehl S, Aichele P: Adoptive T cell therapy cures mice from active hemophagocytic lymphohistiocytosis (HLH). EMBO molecular medicine 2022, 14:e16085 [PMID: 36278424] WEI2022
  34. Groenendijk A, van Tinteren H, Jiang Y, de Krijger RR, Vujanic GM, Godzinski J, Rübe C, Schenk JP, Morosi C, Pritchard-Jones K, Al-Saadi R, Vaidya SJ, Verschuur AC, Ramírez-Villar GL, Graf N, de Camargo B, Drost J, Perotti D, van den Heuvel-Eibrink MM, Brok J, Spreafico F, Mavinkurve-Groothuis AMC: Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols. European journal of cancer 2022, 163: 88 [PMID: 35042071] GRO2022
  35. Mifsud W, Furtwängler R, Vokuhl C, D'Hooghe E, Pritchard-Jones K, Graf N, Vujanić GM: Treatment of patients with stage I focal anaplastic and diffuse anaplastic Wilms tumour: A report from the SIOP-WT-2001 GPOH and UK-CCLG studies. European journal of cancer 2022, 166: 1 [PMID: 35255331] MIS2022
  36. van der Perk MEM, Cost NG, Bos AME, Brannigan R, Chowdhury T, Davidoff AM, Daw NC, Dome JS, Ehrlich P, Graf N, Geller J, Kalapurakal J, Kieran K, Malek M, McAleer MF, Mullen E, Pater L, Polanco A, Romao R, Saltzman AF, Walz AL, Woods AD, van den Heuvel-Eibrink MM, Fernandez CV: White paper: Oncofertility in pediatric patients with Wilms tumor. International journal of cancer 2022, 151: 843 [PMID: 35342935] PER2022
  37. Beck P, Selle B, Madenach L, Jones DTW, Vokuhl C, Gopisetty A, Nabbi A, Brecht IB, Ebinger M, Wegert J, Graf N, Gessler M, Pfister SM, Jäger N: The genomic landscape of pediatric renal cell carcinomas. iScience 2022, 25: 104167 [PMID: 35445187] BEC2022
  38. de Aguirre-Neto JC, de Camargo B, van Tinteren H, Bergeron C, Brok J, Ramírez-Villar G, Verschuur A, Furtwängler R, Howell L, Saunders D, Olsen O, Coulomb A, Vokuhl C, Godzinski J, Smets AM, Vujanic GM, van den Heuvel-Eibrink MM, Graf N, Pritchard-Jones K: International Comparisons of Clinical Demographics and Outcomes in the International Society of Pediatric Oncology Wilms Tumor 2001 Trial and Study. JCO global oncology 2022, 8:e2100425 [PMID: 35537105] AGU2022
  39. Meier CM, Furtwängler R, von Schweinitz D, Stein R, Welter N, Wagenpfeil S, Kager L, Schenk JP, Vokuhl C, Melchior P, Fuchs J, Graf N: Vena Cava Thrombus in Patients with Wilms Tumor. Cancers 2022, 14 [PMID: 36010917] MEI2022
  40. Jackson TJ, Brisse HJ, Pritchard-Jones K, Nakata K, Morosi C, Oue T, Irtan S, Vujanic G, van den Heuvel-Eibrink MM, Graf N, Chowdhury T, SIOP RTSG Biopsy Working Group: How we approach paediatric renal tumour core needle biopsy in the setting of preoperative chemotherapy: A Review from the SIOP Renal Tumour Study Group. Pediatric blood & cancer 2022, 69:e29702 [PMID: 35587187] JAC2022
  41. Graf M, Interlandi M, Moreno N, Holdhof D, Göbel C, Melcher V, Mertins J, Albert TK, Kastrati D, Alfert A, Holsten T, de Faria F, Meisterernst M, Rossig C, Warmuth-Metz M, Nowak J, Meyer Zu Hörste G, Mayère C, Nef S, Johann P, Frühwald MC, Dugas M, Schüller U, Kerl K: Single-cell transcriptomics identifies potential cells of origin of MYC rhabdoid tumors. Nature communications 2022, 13: 1544 [PMID: 35318328] GRA2022
  42. Schenk JP, Hötker A, Furtwängler R, Fuchs J, Warmann SW, Graf N: [Imaging of renal tumors in children]. Der Radiologe 2021, 61: 619 [PMID: 34143242] SCH2021e
  43. Welter N, Wagner A, Furtwängler R, Melchior P, Kager L, Vokuhl C, Schenk JP, Meier CM, Siemer S, Gessler M, Graf N: Correction: Welter et al. Characteristics of Nephroblastoma/Nephroblastomatosis in Children with a Clinically Reported Underlying Malformation or Cancer Predisposition Syndrome. Cancers 2021, 13, 5016. Cancers 2021, 13 [PMID: 34831025] WEL2021a
  44. Brok J, Mavinkurve-Groothuis AMC, Drost J, Perotti D, Geller JI, Walz AL, Geoerger B, Pasqualini C, Verschuur A, Polanco A, Jones KP, van den Heuvel-Eibrink M, Graf N, Spreafico F: Unmet needs for relapsed or refractory Wilms tumour: Mapping the molecular features, exploring organoids and designing early phase trials - A collaborative SIOP-RTSG, COG and ITCC session at the first SIOPE meeting. European journal of cancer 2021, 144: 113 [PMID: 33341445] BRO2021a
  45. Hol JA, Jewell R, Chowdhury T, Duncan C, Nakata K, Oue T, Gauthier-Villars M, Littooij AS, Kaneko Y, Graf N, Bourdeaut F, van den Heuvel-Eibrink MM, Pritchard-Jones K, Maher ER, Kratz CP, Jongmans MCJ: Wilms tumour surveillance in at-risk children: Literature review and recommendations from the SIOP-Europe Host Genome Working Group and SIOP Renal Tumour Study Group. European journal of cancer (Oxford, England : 1990) 2021, 153: 51 [PMID: 34134020] HOL2021a
  46. Friesenbichler W, Lüftinger R, Kropshofer G, Henkel M, Amann G, Furtwängler R, Graf N, Kager L: Clear cell sarcoma of the kidney in Austrian children: Long-term survival after relapse. Pediatric blood & cancer 2021, 68:e28860 [PMID: 33438324] FRI2021
  47. Dávila Fajardo R, Furtwängler R, van Grotel M, van Tinteren H, Pasqualini C, Pritchard-Jones K, Al-Saadi R, de Camargo B, Ramírez Villar GL, Graf N, Muracciole X, Melchior P, Saunders D, Rübe C, van den Heuvel-Eibrink MM, Janssens GO, Verschuur AC: Outcome of Stage IV Completely Necrotic Wilms Tumour and Local Stage III Treated According to the SIOP 2001 Protocol. Cancers 2021, 13 [PMID: 33652659] DAV2021
  48. Vujanić GM, D'Hooghe E, Graf N, Vokuhl C, Al-Saadi R, Chowdhury T, Pritchard-Jones K, Furtwängler R: Prognostic significance of histopathological response to preoperative chemotherapy in unilateral Wilms' tumor: An analysis of 899 patients treated on the SIOP WT 2001 protocol in the UK-CCLG and GPOH studies. International journal of cancer 2021, 149: 1332 [PMID: 34109628] VUJ2021
  49. Graf N, Bergeron C, Brok J, de Camargo B, Chowdhury T, Furtwängler R, Gessler M, Godzinski J, Pritchard-Jones K, Ramirez-Villar GL, Rübe C, Sandstedt B, Schenk JP, Spreafico F, Sudour-Bonnange H, van Tinteren H, Verschuur A, Vujanic G, van den Heuvel-Eibrink MM: Fifty years of clinical and research studies for childhood renal tumors within the International Society of Pediatric Oncology (SIOP). Annals of oncology 2021, 32: 1327 [PMID: 34416363] GRA2021
  50. Welter N, Wagner A, Furtwängler R, Melchior P, Kager L, Vokuhl C, Schenk JP, Meier CM, Siemer S, Gessler M, Graf N: Characteristics of Nephroblastoma/Nephroblastomatosis in Children with a Clinically Reported Underlying Malformation or Cancer Predisposition Syndrome. Cancers 2021, 13 [PMID: 34638500] WEL2021
  51. van der Beek JN, Hol JA, Coulomb-l'Hermine A, Graf N, van Tinteren H, Pritchard-Jones K, Houwing ME, de Krijger RR, Vujanic GM, Dzhuma K, Schenk JP, Littooij AS, Ramírez-Villar GL, Murphy D, Ray S, Al-Saadi R, Gessler M, Godzinski J, Ruebe C, Collini P, Verschuur AC, Frisk T, Vokuhl C, Hulsbergen-van de Kaa CA, de Camargo B, Sandstedt B, Selle B, Tytgat GAM, van den Heuvel-Eibrink MM: Characteristics and outcome of pediatric renal cell carcinoma patients registered in the International Society of Pediatric Oncology (SIOP) 93-01, 2001 and UK-IMPORT database: A report of the SIOP-Renal Tumor Study Group. International journal of cancer 2021, 148: 2724 [PMID: 33460450] BEE2021
  52. Dávila Fajardo R, Furtwängler R, van Grotel M, van Tinteren H, Pasqualini C, Pritchard-Jones K, Al-Saadi R, de Camargo B, Ramírez Villar GL, Graf N, Muracciole X, Melchior P, Saunders D, Rübe C, van den Heuvel-Eibrink MM, Janssens GO, Verschuur AC: Outcome of Stage IV Completely Necrotic Wilms Tumour and Local Stage III Treated According to the SIOP 2001 Protocol. Cancers 2021, 13 [PMID: 33652659] DAV2021
  53. Mul J, Melchior P, Seravalli E, Saunders D, Bolle S, Cameron AL, Gurtner K, Harrabi S, Lassen-Ramshad Y, Lavan N, Magelssen H, Mandeville H, Boterberg T, Kroon PS, Kotte ANTJ, Hoeben BAW, van Rossum PSN, van Grotel M, Graf N, van den Heuvel-Eibrink MM, Rübe C, Janssens GO: Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise. Clinical and translational radiation oncology 2021, 28: 39 [PMID: 33796796] MUL2021
  54. Vujanić GM, D'Hooghe E, Graf N, Vokuhl C, Al-Saadi R, Chowdhury T, Pritchard-Jones K, Furtwängler R: Prognostic significance of histopathological response to preoperative chemotherapy in unilateral Wilms' tumor: An analysis of 899 patients treated on the SIOP WT 2001 protocol in the UK-CCLG and GPOH studies. International journal of cancer 2021, 149: 1332 [PMID: 34109628] VUJ2021
  55. Groenendijk A, Spreafico F, de Krijger RR, Drost J, Brok J, Perotti D, van Tinteren H, Venkatramani R, Godziński J, Rübe C, Geller JI, Graf N, van den Heuvel-Eibrink MM, Mavinkurve-Groothuis AMC: Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature. Cancers 2021, 13 [PMID: 34201787] GRO2021
  56. Grainger JD, Kühne T, Hippenmeyer J, Cooper N: Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia. Annals of hematology 2021, Online ahead of print [PMID: 34308495] GRA2021
  57. Spreafico F, Dalissier A, Pötschger U, Locatelli F, Michon JM, Peters C, Bader P, Bisogno G, Yeomanson D, Willasch A, van den Heuvel Eibrink M, Graf N, Dallorso S, EBMT Paediatric Diseases Working Party: High dose chemotherapy and autologous hematopoietic cell transplantation for Wilms tumor: a study of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation 2020, 55: 376 [PMID: 31534191] SPR2020
  58. Fajardo RD, van den Heuvel-Eibrink MM, van Tinteren H, Spreafico F, Acha T, Bergeron C, de Camargo B, Oldenburger F, Rübe C, Oue T, Vokuhl C, de Krijger RR, Vujanic G, Sebire N, Coulomb-L'Hermine A, Collini P, Gandola L, Pritchard-Jones K, Graf N, Janssens GO, van Grotel M: Is radiotherapy required in first-line treatment of stage I diffuse anaplastic Wilms tumor? A report of SIOP-RTSG, AIEOP, JWiTS, and UKCCSG. Pediatric blood & cancer 2020, 67:e28039 [PMID: 31625685] FAJ2020
  59. Pasqualini C, Furtwängler R, van Tinteren H, Teixeira RAP, Acha T, Howell L, Vujanic G, Godzinski J, Melchior P, Smets AM, Coulomb-L'Hermine A, Brisse H, Pritchard-Jones K, Bergeron C, de Camargo B, van den Heuvel-Eibrink MM, Graf N, Verschuur AC: Outcome of patients with stage IV high-risk Wilms tumour treated according to the SIOP2001 protocol: A report of the SIOP Renal Tumour Study Group. European journal of cancer 2020, 128: 38 [PMID: 32109849] PAS2020
  60. Gessler M, Graf N: Less may be more for stage I epithelial Wilms tumors. Cancer 2020, 126: 2762 [PMID: 32267965] GES2020
  61. van der Beek JN, Geller JI, de Krijger RR, Graf N, Pritchard-Jones K, Drost J, Verschuur AC, Murphy D, Ray S, Spreafico F, Dzhuma K, Littooij AS, Selle B, Tytgat GAM, van den Heuvel-Eibrink MM: Characteristics and Outcome of Children with Renal Cell Carcinoma: A Narrative Review. Cancers 2020, 12 [PMID: 32635225] BEE2020
  62. Janssens GO, Melchior P, Mul J, Saunders D, Bolle S, Cameron AL, Claude L, Gurtner K, van de Ven KP, van Grotel M, Harrabi S, Lassen-Ramshad Y, Lavan N, Magelssen H, Muracciole X, Boterberg T, Mandeville H, Godzinski J, Graf N, van den Heuvel-Eibrink MM, Rübe C: The SIOP-Renal Tumour Study Group consensus statement on flank target volume delineation for highly conformal radiotherapy. The Lancet 2020, 4: 846 [PMID: 33068550] JAN2020
  63. Irtan S, Van Tinteren H, Graf N, van den Heuvel-Eibrink MM, Heij H, Bergeron C, de Camargo B, Acha T, Spreafico F, Vujanic G, Powis M, Okoye B, Wilde J, Godzinski J, Pritchard-Jones K: Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms tumour in the SIOP WT 2001 trial. European journal of cancer 2019, 116: 13 [PMID: 31163337] IRT2019
  64. Vokuhl C, Nourkami-Tutdibi N, Furtwängler R, Gessler M, Graf N, Leuschner I: ETV6-NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study. Pediatric blood & cancer 2018, 65 [PMID: 29286563] VOK2018
  65. Dávila Fajardo R, Oldenburger E, Rübe C, López-Yurda M, Pritchard-Jones K, Bergeron C, Graf N, van Grotel M, van Tinteren H, Saunders D, van den Heuvel-Eibrink MM, Janssens GO, Oldenburger F: Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: Results from the SIOP-WT-2001 Registry. Pediatric blood & cancer 2018, 65:e27085 [PMID: 29693799] DAV2018
  66. Hol JA, van den Heuvel-Eibrink MM, Graf N, Pritchard-Jones K, Brok J, van Tinteren H, Howell L, Verschuur A, Bergeron C, Kager L, Catania S, Spreafico F, Mavinkurve-Groothuis AMC: Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study Group. Pediatric blood & cancer 2018, 65 [PMID: 29077255] HOL2018
  67. Wegert J, Vokuhl C, Ziegler B, Ernestus K, Leuschner I, Furtwängler R, Graf N, Gessler M: TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia. The journal of pathology. Clinical research 2017, 3: 234 [PMID: 29085664] WEG2017
  68. van den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K, van Tinteren H, Furtwängler R, Verschuur AC, Vujanic GM, Leuschner I, Brok J, Rübe C, Smets AM, Janssens GO, Godzinski J, Ramí­rez-Villar GL, de Camargo B, Segers H, Collini P, Gessler M, Bergeron C, Spreafico F, Graf N, International Society of Paediatric Oncology -Renal Tumour Study Group (SIOP-RTSG): Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol. Nature reviews. Urology 2017, 14: 743 [PMID: 29089605] HEU2017
  69. Gooskens SL, Segers H, Pritchard-Jones K, Graf N, Dome JS, van den Heuvel-Eibrink MM, van den Heuvel-Eibrink MM: The Clinical Relevance of Age at Presentation in Nephroblastoma. 2016, [PMID: 27512763] GOO2016
  70. Chagtai T, Zill C, Dainese L, Wegert J, Savola S, Popov S, Mifsud W, Vujanic‡ G, Sebire N, Le Bouc Y, Ambros PF, Kager L, O'Sullivan MJ, Blaise A, Bergeron C, Mengelbier LH, Gisselsson D, Kool M, Tytgat GA, van den Heuvel-Eibrink MM, Graf N, van Tinteren H, Coulomb A, Gessler M, Williams RD, Pritchard-Jones K: Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Sep 10; 34: 3195 [PMID: 27432915] CHA2016
  71. Dome JS, Graf N, Geller JI, Fernandez CV, Mullen EA, Spreafico F, Van den Heuvel-Eibrink M, Pritchard-Jones K: Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Sep 20; 33: 2999 [PMID: 26304882] DOM2015
  72. van den Heuvel-Eibrink MM, van Tinteren H, Bergeron C, Coulomb-L'Hermine A, de Camargo B, Leuschner I, Sandstedt B, Acha T, Godzinski J, Oldenburger F, Gooskens SL, de Kraker J, Vujanic GM, Pritchard-Jones K, Graf N: Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG). European journal of cancer (Oxford, England : 1990) 2015,Epub ahead of print [PMID: 25592561] HEU2015
  73. Dome JS, Perlman EJ, Graf N: Risk stratification for wilms tumor: current approach and future directions. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2014,: 215 [PMID: 24857079] DOM2014
  74. Furtwängler R, Schmolze M, Gräber S, Leuschner I, Amann G, Schenk JP, Niggli F, Kager L, von Schweinitz D, Graf N: Pretreatment for bilateral nephroblastomatosis is an independent risk factor for progressive disease in patients with stage V nephroblastoma. Klinische Padiatrie 2014, 226: 175 [PMID: 24819388] FUR2014
  75. Mavinkurve-Groothuis AM, van den Heuvel-Eibrink MM, Tytgat GA, van Tinteren H, Vujanic G, Pritchard-Jones KL, Howell L, Graf N, Bergeron C, Acha T, Catania S, Spreafico F: Treatment of relapsed Wilms tumour (WT) patients: Experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG). Pediatric blood & cancer 2014, epub ahead of print [PMID: 25546733] MAV2014
  76. Graf N, Furtwaengler R: Preoperative chemotherapy and local stage III in nephroblastoma. Translational Pediatrics 2014, 3 [DOI: 10.3978/j.issn.2224-4336.2013.12.02] GRA2013
  77. Furtwängler R, Gooskens SL, van Tinteren H, de Kraker J, Schleiermacher G, Bergeron C, de Camargo B, Acha T, Godzinski J, Sandstedt B, Leuschner I, Vujanic GM, Pieters R, Graf N, van den Heuvel-Eibrink MM: Clear Cell Sarcomas of the Kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: A report of the SIOP Renal Tumour Study Group. European journal of cancer (Oxford, England : 1990) 2013, epub ahead of print [PMID: 23880476] FUR2013
  78. Berger M, Fernandez-Pineda I, Cabello R, Ramírez-Villar GL, Márquez-Vega C, Nustede R, Linderkamp C, Schmid I, Neth O, Graf N, Agustin JC, Schweinitz DV, Lacher M, Hubertus J: The Relationship Between the Site of Metastases and Outcome in Children With Stage IV Wilms Tumor: Data From 3 European Pediatric Cancer Institutions. Journal of pediatric hematology/oncology 2013, Epub ahead of print [PMID: 23588334] BER2013
  79. Warmann SW, Nourkami N, Frühwald M, Leuschner I, Schenk JP, Fuchs J, Graf N: Primary Lung Metastases in Pediatric Malignant Non-Wilms Renal Tumors: Data from SIOP 93-01/GPOH and SIOP 2001/GPOH. Klinische Padiatrie 2012, 224: 148 [PMID: 22513793] WAR2012
  80. Furtwängler R, Nourkami N, Alkassar M, von Schweinitz D, Schenk JP, Rübe C, Siemer S, Leuschner I, Graf N: Update on relapses in unilateral nephroblastoma registered in 3 consecutive SIOP/GPOH studies - a report from the GPOH-nephroblastoma study group. Klin padiatr 2011, 223: 113 [PMID: 21509706] FUR2011
  81. Schenk JP, Gunther P, Schrader C, Ley S, Furtwangler R, Leuschner I, Edelhauser M, Graf N, Troger J: [Childhood kidney tumors - the relevance of imaging.] Der Radiologe 2005, 45: 1112 [PMID: 16151729] SCH2005f
  82. Schenk JP, Schrader C, Furtwangler R, Ko HS, Leuschner I, Graf N, Troeger J: [MRI-morphology and staging of congenital mesoblastic nephroma: evaluation of a collection with 20 patients]. RoFo 2005, 177: 1373 [PMID: 16170706] SCH2005e
  83. Schlomm T, Gunawan B, Schulten HJ, Sander B, Thangavelu K, Graf N, Leuschner I, Ringert RH, Fuzesi L: Effects of chemotherapy on the cytogenetic constitution of Wilms' tumor. Clinical cancer research 2005, 11: 4382 [PMID: 15958621] SCH2005d
  84. Zirn B, Hartmann O, Samans B, Krause M, Wittmann S, Mertens F, Graf N, Eilers M, Gessler M: Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters. International journal of cancer 2006, 118: 1954 [PMID: 16287080] ZIR2005c
  85. Schenk JP, Engelmann D, Zieger B, Semler O, Wuhl E, Furtwangler R, Graf N, Troger J: [Radiologic differentiation of rhabdoid tumor from Wilms' tumor and mesoblastic nephroma]. Der Urologe. Ausg. A 2005, 44: 155 [PMID: 15672236] SCH2005c
  86. Zirn B, Samans B, Wittmann S, Pietsch T, Leuschner I, Graf N, Gessler M: Target genes of the WNT/beta-catenin pathway in Wilms tumors. Genes, chromosomes & cancer 2006, 45: 565 [PMID: 16575872] ZIR2005b
  87. Zirn B, Samans B, Spangenberg C, Graf N, Eilers M, Gessler M: All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo. Oncogene 2005, 24: 5246 [PMID: 15897880] ZIR2005a
  88. Zirn B, Wittmann S, Graf N, Gessler M: Chibby, a novel antagonist of the Wnt pathway, is not involved in Wilms tumor development. Cancer letters 2005, 220: 115 [PMID: 15737694] ZIR2005
  89. Schenk JP, Waag KL, Graf N, Wunsch R, Jourdan C, Behnisch W, Troger J, Gunther P: [3D-visualization by MRI for surgical planning of Wilms tumors]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 2004, 176: 1447 [PMID: 15383976] SCH2004f
  90. Reinhard H, Aliani S, Ruebe C, Stockle M, Leuschner I, Graf N: Wilms' tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004, 22: 4500 [PMID: 15542800] REI2004c
  91. van den Heuvel-Eibrink MM, Graf N, Pein F, Sandstedt B, van Tinteren H, van der Vaart KE, de Kraker J: Intracranial relapse in Wilms tumor patients. Pediatric blood & cancer 2004, 43: 737 [PMID: 15390287] VAN2004
  92. de Kraker J, Graf N, van Tinteren H, Pein F, Sandstedt B, Godzinski J, Tournade MF, SIOP: Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial. Lancet 2004, 364: 1229 [PMID: 15464183] DEK2004
  93. Siemer S, Lehmann J, Reinhard H, Graf N, Loffler G, Hendrik H, Remberger K, Stockle M: Prenatal diagnosis of congenital mesoblastic nephroma associated with renal hypertension in a premature child. International journal of urology : official journal of the Japanese Urological Association 2004, 11: 50 [PMID: 14678186] SIE2004